Magnetic bead technology in viral RNA and DNA extraction from plasma minipools
- 29 June 2005
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 45 (7) , 1106-1110
- https://doi.org/10.1111/j.1537-2995.2005.04356.x
Abstract
BACKGROUND:Nucleic acid testing (NAT) of pooled plasma samples from individual blood donations for viral nucleic acids has become widely established. Full automation of such sample processing can overcome many of the problems associated with methods used so far.STUDY DESIGN AND METHODS:In this study an automated extraction method for viral nucleic acids (parvovirus [PAV] B19 DNA, hepatitis B virus [HBV] DNA, and hepatitis A virus [HAV] RNA), starting directly from the minipool sample (n = 96, 9.6 mL), was evaluated. A magnetic separation module I (chemagic, Polymer Laboratories) in combination with the chemagic viral DNA and RNA kit special based on the use of magnetic beads was used for this purpose. More than 144 pools spiked with defined concentrations of reference material and an additional 102 pools negative for the analyte were extracted and amplified. The isolated viral nucleic acids were detected by polymerase chain reaction (PCR).RESULTS:The assays were highly specific and obtained a 95 percent detection limit of 875 IU per mL of pooled single donation for PAV B19, 260 IU per mL for HAV, and 1274 IU per mL for HBV, respectively. The crossing points showed variation coefficients from 1.49 to 2.76 percent. The turnaround time for the whole process was 3 hours. Testing of subpools to determine an infected single donation would be possible with the same general extraction method. A total of 102 unspiked minipools (96 × 100 µL per donation) were analyzed and none tested positive.CONCLUSION:The automated magnetic bead–based extraction in combination with real‐time PCR detection can be used to routinely screen blood donations for viremic donors to further increase the safety of blood products. Minipools as well as subpools can be directly processed.Keywords
This publication has 8 references indexed in Scilit:
- The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donationsTransfusion, 2003
- Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non‐structural viral proteinsVox Sanguinis, 2003
- Recent developments in laboratory automation using magnetic particles for genome analysisPharmacogenomics, 2002
- The German experience with NAT.Transfusion Medicine, 2002
- US NAT yield: where are we after 2 years?Transfusion Medicine, 2002
- Automation of nucleic acid extraction for NAT screening of individual blood unitsTransfusion, 2001
- NAT and Viral Safety In Blood TransfusionVox Sanguinis, 2000
- The Optimal Treatment for Haemophiliacs Who Have Developed Factor VIII or -IX AntibodiesVox Sanguinis, 2000